ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 47 filers reported holding ONCOCYTE CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,088 | +10.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6,420 | -57.2% | 20,000 | 0.0% | 0.00% | -60.0% |
| Q3 2022 | $15,000 | -16.7% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $18,000 | -40.0% | 20,000 | 0.0% | 0.01% | -40.0% |
| Q1 2022 | $30,000 | -30.2% | 20,000 | 0.0% | 0.02% | -31.0% |
| Q4 2021 | $43,000 | -39.4% | 20,000 | 0.0% | 0.03% | -49.1% |
| Q3 2021 | $71,000 | -38.3% | 20,000 | 0.0% | 0.06% | -3.4% |
| Q2 2021 | $115,000 | +10.6% | 20,000 | 0.0% | 0.06% | 0.0% |
| Q1 2021 | $104,000 | – | 20,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,596,680 | $16,725,000 | 2.33% |
| Artal Group S.A. | 150,000 | $698,000 | 0.01% |
| Destination Wealth Management | 29,656 | $138,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $674,000 | 0.01% |
| IHT Wealth Management, LLC | 563 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 695 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 44,048 | $205,000 | 0.00% |
| Vantage Investment Advisors, LLC | 25 | $0 | 0.00% |
| UBS Group AG | 5,204 | $24,000 | 0.00% |
| Legal & General Group Plc | 384 | $2,000 | 0.00% |